- Report
- August 2022
- 120 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- August 2022
- 119 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- July 2022
- 112 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- November 2021
- 101 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- October 2022
- 120 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- February 2024
- 114 Pages
Global
From €4013EUR$4,250USD£3,442GBP
- Report
- January 2024
- 145 Pages
Global
From €4013EUR$4,250USD£3,442GBP
- Report
- February 2024
- 30 Pages
Global
€3352EUR$3,550USD£2,875GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4674EUR$4,950USD£4,009GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4674EUR$4,950USD£4,009GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4674EUR$4,950USD£4,009GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4674EUR$4,950USD£4,009GBP
- Report
- January 2024
- 106 Pages
Global
From €3729EUR$3,950USD£3,199GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1416EUR$1,500USD£1,215GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1416EUR$1,500USD£1,215GBP
- Report
- November 2023
- 30 Pages
Global
From €2596EUR$2,750USD£2,227GBP
- Report
- November 2023
- 30 Pages
Global
From €3069EUR$3,250USD£2,632GBP
- Report
- June 2023
- 200 Pages
Global
From €7081EUR$7,500USD£6,075GBP
- Report
- April 2023
- 140 Pages
Global
From €8970EUR$9,500USD£7,695GBP
- Report
- April 2023
- 240 Pages
Global
From €3305EUR$3,500USD£2,835GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more